Hepatic cholesterol transport and its role in non-alcoholic fatty liver disease and atherosclerosis

H Li, XH Yu, X Ou, XP Ouyang, CK Tang - Progress in lipid research, 2021 - Elsevier
Non-alcoholic fatty liver disease (NAFLD) is a quickly emerging global health problem
representing the most common chronic liver disease in the world. Atherosclerotic …

Central nervous system lipoproteins: ApoE and regulation of cholesterol metabolism

RW Mahley - Arteriosclerosis, thrombosis, and vascular biology, 2016 - Am Heart Assoc
ApoE on high-density lipoproteins is primarily responsible for lipid transport and cholesterol
homeostasis in the central nervous system (CNS). Normally produced mostly by astrocytes …

Liver X receptors in lipid metabolism: opportunities for drug discovery

C Hong, P Tontonoz - Nature reviews Drug discovery, 2014 - nature.com
The liver X receptors (LXRs) are pivotal regulators of lipid homeostasis in mammals. These
transcription factors control the expression of a battery of genes involved in the uptake …

Cholesterol efflux and atheroprotection: advancing the concept of reverse cholesterol transport

RS Rosenson, HB Brewer Jr, WS Davidson, ZA Fayad… - Circulation, 2012 - Am Heart Assoc
High-density lipoprotein (HDL) has been proposed to have several antiatherosclerotic
properties, including the ability to mediate macrophage cholesterol efflux, antioxidant …

The role of the ATP-binding cassette A1 (ABCA1) in human disease

L Jacobo-Albavera, M Domínguez-Pérez… - International journal of …, 2021 - mdpi.com
Cholesterol homeostasis is essential in normal physiology of all cells. One of several
proteins involved in cholesterol homeostasis is the ATP-binding cassette transporter A1 …

Molecular biology of atherosclerosis

PN Hopkins - Physiological reviews, 2013 - journals.physiology.org
At least 468 individual genes have been manipulated by molecular methods to study their
effects on the initiation, promotion, and progression of atherosclerosis. Most clinicians and …

Rare dyslipidaemias, from phenotype to genotype to management: a European Atherosclerosis Society task force consensus statement

RA Hegele, J Borén, HN Ginsberg, M Arca… - The lancet Diabetes & …, 2020 - thelancet.com
Genome sequencing and gene-based therapies appear poised to advance the
management of rare lipoprotein disorders and associated dyslipidaemias. However, in …

An abundant dysfunctional apolipoprotein A1 in human atheroma

Y Huang, JA DiDonato, BS Levison, D Schmitt, L Li… - Nature medicine, 2014 - nature.com
Recent studies have indicated that high-density lipoproteins (HDLs) and their major
structural protein, apolipoprotein A1 (apoA1), recovered from human atheroma are …

Role of cholesterol and lipid rafts in cancer signaling: a promising therapeutic opportunity?

R Vona, E Iessi, P Matarrese - Frontiers in cell and developmental …, 2021 - frontiersin.org
Cholesterol is a lipid molecule that plays an essential role in a number of biological
processes, both physiological and pathological. It is an essential structural constituent of cell …

Obesity, diabetes, and cardiovascular diseases: a compendium

PE Scherer, JA Hill - Circulation research, 2016 - Am Heart Assoc
1704 Circulation Research May 27, 2016 of epigenetic mechanisms contributing to
macrovascular disease in diabetes. The authors highlight the recent identification of …